Skip to main content
Fig. 2 | Journal of Inflammation

Fig. 2

From: Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion

Fig. 2

Correlation between the change of the aqueous flare value and improvement of BCVA or CMT at 1 month after intravitreal ranibizumab injection (IRI). a There was no significant correlation between the change of the aqueous flare value and improvement of BCVA at 1 month after IRI (ρ = − 0.01, P = 0.952). b There was also no significant correlation between the change of the aqueous flare value and improvement of CMT at 1 month after IRI (ρ = 0.03, P = 0.887)

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us